Supersalud scheduled 417 audits of EPS, hospitals, and pharmaceutical managers for 2026

The plan represents a 66% increase compared to the 251 audits carried out in 2025. Photo: Supersalud Courtesy

Supersalud scheduled 417 audits of EPS, hospitals, and pharmaceutical managers for 2026

TL;DR

  • Supersalud will conduct 417 audits in 2026, a 66% increase from 251 audits in 2025.
  • Audits will focus on EPS, hospitals, pharmaceutical managers, and other health system actors.
  • The strategy prioritizes territories with higher alerts in service provision.
  • The goal is to verify compliance with obligations and protect user rights.
  • A risk-based supervision model will be employed to focus control processes on institutions and regions with the most alerts.
  • Specialized technical teams with health sector experience will conduct the audits.
  • Supersalud aims to advance verification of system regulations and oversight of service providers.